Breast cancer advancements expected in 2018
December 29, 2017 06:13 AM
The opioid crisis and attempts to repeal Obamacare topped health news in 2017. So what can we expect in the new year?
Researchers are expecting advancements in more targeted treatments for breast cancer. These drugs attack specific pathways in cancer cells and are already on the market for ovarian cancer.
There is hope the FDA will approve them for use in breast cancer in 2018.
Created: December 29, 2017 06:13 AM
Copyright 2017 - WNYT-TV, LLC A Hubbard Broadcasting Company